InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Peter Greenleaf, Chief Executive Officer, is a corporate insider tracked by InsiderTape across 2 companies. The public record shows 6 open-market SEC Form 4 transactions: 0 purchases worth $0 and 6 sales worth $4.0M, reported from Mar 2, 22 to Jul 2, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 2, 26 | PTHSPelthos Therapeutics Inc. | SELL | 712 | $27.27 | $19K |
| Mar 4, 25 | AUPHAurinia Pharmaceuticals Inc. | SELL | 164.9K | $7.92 | $1.3M |
| Mar 3, 25 | AUPHAurinia Pharmaceuticals Inc. | SELL | 195.6K | $8.00 | $1.6M |
| Mar 6, 24 | AUPHAurinia Pharmaceuticals Inc. | SELL | 127.0K | $5.60 | $711K |
| Mar 2, 23 | AUPHAurinia Pharmaceuticals Inc. | SELL | 33.0K | $8.94 | $293K |
| Mar 2, 22 | AUPHAurinia Pharmaceuticals Inc. | SELL | 9.1K | $12.01 | $109K |